SCHEDULE: Impactive Capital Reduces Clarivate PLC Stake to 3.5%

Impactive Capital and its affiliates have significantly reduced their beneficial ownership in Clarivate PLC, selling over 15.8 million shares in the past 60 days.

Summary

• Impactive Capital LP, Impactive Capital LLC, Lauren Taylor Wolfe, and Christian Asmar (collectively, the "Reporting Persons") have filed an Amendment No. 1 to their Schedule 13D regarding Clarivate PLC.
• The Reporting Persons now beneficially own 23,021,664 Ordinary Shares of Clarivate PLC, representing 3.5% of the class outstanding.
• This percentage is based on 661,435,069 shares outstanding as of September 30, 2025, as disclosed in Clarivate's Form 10-Q.
• The shares were acquired using working capital of the Impactive Funds, totaling approximately $146,406,907, including brokerage commissions.
• During the past sixty days, the Reporting Persons engaged in multiple open market sales of Clarivate PLC shares.
• A total of 15,815,965 shares were sold between December 8, 2025, and February 6, 2026, at prices ranging from $3.6884 down to $1.9976 per share.

Sentiment

Score: 3

Explanation: StockSavvy.ai views this filing negatively due to the substantial divestment by a key institutional investor, Impactive Capital, selling into a declining share price, which suggests a lack of confidence in Clarivate PLC's future.

Negatives

• The Reporting Persons, a significant institutional investor, have substantially reduced their stake in Clarivate PLC by selling over 15.8 million shares.
• The sales occurred over a period where the share price generally declined, from approximately $3.69 to below $2.00, indicating a lack of confidence or a strategic exit at decreasing valuations.

Risks

• Significant selling by a major shareholder like Impactive Capital could signal concerns about the company's future performance or valuation.
• The declining share price during the period of sales suggests potential downward pressure on Clarivate PLC's stock.

Future Outlook

The filing does not contain any forward-looking statements or guidance from Clarivate PLC or the Reporting Persons regarding the company's future performance.

Industry Context

StockSavvy.ai notes that significant reductions in stake by activist or institutional investors like Impactive Capital can sometimes precede periods of underperformance for the underlying company, or reflect a shift in investment strategy by the fund. This move by Impactive Capital could be interpreted by the market as a loss of conviction in Clarivate PLC's near-term prospects, especially given the declining share price during the selling period.

Comparison to Industry Standards

• StockSavvy.ai observes that while institutional investors frequently adjust their positions, a divestment of this magnitude (over 15.8 million shares) by a prominent activist fund like Impactive Capital is notable. Such actions often lead to increased scrutiny from other investors regarding the company's fundamentals and strategic direction.
• Compared to typical institutional portfolio rebalancing, the consistent selling across a declining price range suggests a more deliberate reduction of exposure rather than opportunistic profit-taking at higher valuations.

Stakeholder Impact

• Shareholders: May experience increased selling pressure and negative sentiment due to a major investor reducing its stake, potentially impacting share price.
• Company Management: May face questions from other investors regarding the reasons for Impactive Capital's divestment and the company's strategic direction.

Key Dates

Recommendation

The substantial and consistent selling by a major institutional investor like Impactive Capital, particularly into a declining share price, signals a strong lack of conviction in Clarivate PLC's prospects. This action could lead to further downward pressure on the stock, making a 'sell' recommendation appropriate for investors seeking to mitigate potential losses or reallocate capital.

Keywords

Clarivate PLC, Impactive Capital, Schedule 13D/A, Share Sales, Beneficial Ownership, Institutional Investor, G21810109, Ordinary Shares